Driving Regulatory Progress for Inherited Ataxias: CPTA’s Impact in Advocacy and Change By Alexander Diegel and Terina Martinez Inherited ataxias are a diverse collection of genetic disorders that are characterized by
Innovative Model-informed Drug Development Tools to Inform Trial Design in Neurological Diseases By the C-Path Quantitative Medicine Team Summary: Through its collaborations with the Critical Path Institute (C-Path), CDER
How C-Path’s Biomarker Data Repository Brings Patients to the Table to Discuss Biomarkers and Their Impact By: Claire Bassetti C-Path publicly launched its Biomarker Data Repository (BmDR) in 2023 to advance the qualification of novel bi
Strength in Service: A Young Mother’s Battle with ALS By Alexander Diegel In October of 2022, 38-year-old Melissa Diaz-Viera was a new mom to a happy eight-month-old baby and had
Bending the Curve: Sarah Zenner-Dolan’s Advocacy Journey with Parkinson’s Disease At Critical Path Institute’s 20 Year Gala on Feb.10, 2025, Sarah Zenner-Dolan shared her personal mission and journey with P
C-Path Opportunities Table In 2004, the Food and Drug Administration launched the Critical Path Initiative (CPI) to drive innovation in the scientific proces
C-Path’s Alzheimer’s Disease Simulator Featured in the Wall Street Journal We were excited to be included in The Wall Street Journal earlier this week discussing the value of the Critical Path In
Given No Answers After a Life-Changing Diagnosis, Pat Furlong Worked to Create Her Own It was 40 years ago that Pat Furlong faced a heart-wrenching diagnosis for any parent; her sons Christopher and Patrick were diagn
Living with ARPKD Presents Challenges, Opportunities for Cormack Family When Lisa Cormack’s daughter Jana was 4 years old, she went to the pediatrician for a typical preschool physical. A healthy, hap
For Judy Ashley’s Family, ADPKD Impact Spans Generations, Sparks Advocacy Work in Community Judy Ashley is one of four siblings living with PKD.